Chemoinformaics analysis of Dichloroacetic acid
| Molecular Weight | 128.942 | nRot | 1 |
| Heavy Atom Molecular Weight | 126.926 | nRig | 1 |
| Exact Molecular Weight | 127.943 | nRing | 0 |
| Solubility: LogS | 0.457 | nHRing | 0 |
| Solubility: LogP | 0.824 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 8 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 2 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 10.6376 |
| nHD | 1 | BPOL | 3.89441 |
| QED | 0.533 |
| Synth | 2.4 |
| Natural Product Likeliness | 0.455 |
| NR-PPAR-gamma | 0.068 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.01 |
| HIA | 0.005 |
| CACO-2 | -5.825 |
| MDCK | 0.00306659 |
| BBB | 0.868 |
| PPB | 0.328733 |
| VDSS | 0.337 |
| FU | 0.613187 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.513 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.766 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.665 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.129 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.056 |
| CL | 6.035 |
| T12 | 0.895 |
| hERG | 0.013 |
| Ames | 0.915 |
| ROA | 0.093 |
| SkinSen | 0.507 |
| Carcinogencity | 0.029 |
| EI | 0.022 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.924 |